The potential of dietary treatment in patients with glycogen storage disease type IV.


Journal

Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918

Informations de publication

Date de publication:
05 2021
Historique:
revised: 30 11 2020
received: 21 10 2020
accepted: 07 12 2020
pubmed: 18 12 2020
medline: 28 12 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

There is paucity of literature on dietary treatment in glycogen storage disease (GSD) type IV and formal guidelines are not available. Traditionally, liver transplantation was considered the only treatment option for GSD IV. In light of the success of dietary treatment for the other hepatic forms of GSD, we have initiated this observational study to assess the outcomes of medical diets, which limit the accumulation of glycogen. Clinical, dietary, laboratory, and imaging data for 15 GSD IV patients from three centres are presented. Medical diets may have the potential to delay or prevent liver transplantation, improve growth and normalize serum aminotransferases. Individual care plans aim to avoid both hyperglycaemia, hypoglycaemia and/or hyperketosis, to minimize glycogen accumulation and catabolism, respectively. Multidisciplinary monitoring includes balancing between traditional markers of metabolic control (ie, growth, liver size, serum aminotransferases, glucose homeostasis, lactate, and ketones), liver function (ie, synthesis, bile flow and detoxification of protein), and symptoms and signs of portal hypertension.

Identifiants

pubmed: 33332610
doi: 10.1002/jimd.12339
pmc: PMC8246821
doi:

Substances chimiques

Biomarkers 0
Glycogen 9005-79-2

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

693-704

Informations de copyright

© 2020 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Références

Mol Genet Metab Rep. 2020 May 18;24:100601
pubmed: 32455116
J Hepatol. 1995 Jun;22(6):696-9
pubmed: 7560864
J Inherit Metab Dis. 2021 May;44(3):693-704
pubmed: 33332610
J Inherit Metab Dis. 2020 Mar;43(2):279-289
pubmed: 31587328
J Pediatr Gastroenterol Nutr. 2019 Jun;68(6):763-767
pubmed: 30908382
Pediatr Transplant. 2008 Mar;12(2):137-45
pubmed: 18307661
Am J Med Genet A. 2005 Dec 1;139A(2):118-22
pubmed: 16278887
Mol Genet Metab. 2013 Jun;109(2):179-82
pubmed: 23578772
Mol Ther. 2018 Mar 7;26(3):814-821
pubmed: 29428299
Hepatology. 1988 Mar-Apr;8(2):302-6
pubmed: 3162725
Ann Saudi Med. 2014 Jul-Aug;34(4):354-7
pubmed: 25811211
Am J Transplant. 2012 Nov;12(11):2986-96
pubmed: 22882699
Genet Med. 2019 Dec;21(12):2686-2694
pubmed: 31263214
JIMD Rep. 2019;45:99-104
pubmed: 30569318
J Am Diet Assoc. 1993 Dec;93(12):1423-30
pubmed: 8245377
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S83-90
pubmed: 20058079
Am J Med Genet A. 2006 Apr 15;140(8):878-82
pubmed: 16528737
Pediatr Clin North Am. 2018 Apr;65(2):247-265
pubmed: 29502912
Hum Gene Ther. 2017 Mar;28(3):286-294
pubmed: 27832700
Pediatr Gastroenterol Hepatol Nutr. 2018 Oct;21(4):365-368
pubmed: 30345254
Mol Ther. 2018 Jul 5;26(7):1771-1782
pubmed: 29784585
J Inherit Metab Dis. 1996;19(1):51-8
pubmed: 8830177
Mol Genet Metab Rep. 2016 Oct 04;9:31-33
pubmed: 27747161
Neurology. 2004 Sep 28;63(6):1053-8
pubmed: 15452297
Mamm Genome. 2004 Jul;15(7):570-7
pubmed: 15366377
J Inherit Metab Dis. 2016 Sep;39(5):697-704
pubmed: 27106217
Hum Mol Genet. 2011 Nov 15;20(22):4430-9
pubmed: 21856731
Curr Mol Med. 2002 Mar;2(2):177-88
pubmed: 11949934
Eur J Pediatr. 1986 Aug;145(3):179-81
pubmed: 3464425
Eur J Pediatr. 1993;152 Suppl 1:S71-6
pubmed: 8319729
Nat Med. 2018 Oct;24(10):1519-1525
pubmed: 30297904
Arch Med Sci. 2018 Jan;14(1):237-247
pubmed: 29379554
Lab Invest. 1956 Jan-Feb;5(1):11-20
pubmed: 13279125
Adv Nutr. 2020 Mar 1;11(2):439-446
pubmed: 31665208
Pediatr Res. 1992 Dec;32(6):719-25
pubmed: 1337588

Auteurs

Terry G J Derks (TGJ)

Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Fabian Peeks (F)

Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Foekje de Boer (F)

Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Marieke Fokkert-Wilts (M)

Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Hubert P J van der Doef (HPJ)

Department of Pediatric Gastroenterology Hepatology and Nutrition, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

Marius C van den Heuvel (MC)

Department of Pathology & Medical Biology, Pathology Section, University of Groningen, University Medical Center Groningen, Hanzeplein, Groningen, Netherlands.

Edyta Szymańska (E)

Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Childrens' Memorial Health Institute, Warsaw, Poland.

Dariusz Rokicki (D)

Department of Pediatrics, Nutrition and Metabolic Disorders, The Childrens' Memorial Health Institute, Warsaw, Poland.

Patrick T Ryan (PT)

Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut, USA.

David A Weinstein (DA)

Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
Department of Pediatrics, University of Connecticut Health Center, Farmington, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH